Inhibitors of NF-κB negated the pro-survival effects of RELT expression in esophageal cancer cells, and knockdown of RELT expression in mice decreased the nuclear localization of NF-κB in vivo. The gene discussed is NFKB1; the disease is esophageal cancer.